B-MoGen Biotechnologies, Inc. — Form D
B-MoGen Biotechnologies, Inc. of ST. PAUL, MN, a company, filed a Form D exempt-offering notice with the SEC on 2016-05-16. The offering totals $1.3M, of which $1.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2016-05-16
- Form: D
- Accession: 0001674596-16-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.3M
- Amount sold: $1.0M
- Remaining: $270K
- Investors: 8
- Date of first sale: 2016-05-02
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-263224
Issuer
- Name: B-MoGen Biotechnologies, Inc.
- CIK: 0001674596
- Entity type: Corporation
- Jurisdiction: MINNESOTA
- Incorporated: 2015
- Address: 1246 UNIVERSITY AVE W #301, ST. PAUL, MN, 55104
- Phone: 6123097653
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| David Largaespada | Director | Minneapolis, MN |
| Jeff Liter | Director | Minneapolis, MN |
| Branden Moriarity | Director | Minneapolis, MN |
| Kristin Geisler | Executive Officer | St. Paul, MN |
| Jeff Liter | Executive Officer | Minneapolis, MN |
More